rs150107590
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_144991.3(TSPEAR):c.44C>T(p.Ala15Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00247 in 1,611,590 control chromosomes in the GnomAD database, including 11 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_144991.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TSPEAR | NM_144991.3 | c.44C>T | p.Ala15Val | missense_variant | 1/12 | ENST00000323084.9 | NP_659428.2 | |
TSPEAR | NM_001272037.2 | c.-223C>T | 5_prime_UTR_variant | 1/13 | NP_001258966.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TSPEAR | ENST00000323084.9 | c.44C>T | p.Ala15Val | missense_variant | 1/12 | 1 | NM_144991.3 | ENSP00000321987.4 | ||
TSPEAR | ENST00000642437.1 | n.44C>T | non_coding_transcript_exon_variant | 1/13 | ENSP00000496535.1 |
Frequencies
GnomAD3 genomes AF: 0.00193 AC: 294AN: 152246Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.00245 AC: 596AN: 243458Hom.: 2 AF XY: 0.00262 AC XY: 347AN XY: 132556
GnomAD4 exome AF: 0.00253 AC: 3690AN: 1459226Hom.: 10 Cov.: 30 AF XY: 0.00254 AC XY: 1845AN XY: 725778
GnomAD4 genome AF: 0.00192 AC: 292AN: 152364Hom.: 1 Cov.: 32 AF XY: 0.00193 AC XY: 144AN XY: 74512
ClinVar
Submissions by phenotype
not provided Benign:4
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 28, 2018 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 11, 2024 | - - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jan 01, 2023 | TSPEAR: BP4, BS2 - |
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
TSPEAR-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Sep 27, 2021 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Apr 13, 2017 | p.Ala15Val in exon 1 of TSPEAR: This variant is not expected to have clinical si gnificance because it has been identified in 0.4% (118/30330) of South Asian chr omosomes including 1 homozygote by the Genome Aggregation Database (gnomAD, http ://gnomad.broadinstitute.org; dbSNP rs150107590). - |
Autosomal recessive nonsyndromic hearing loss 98 Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Al Jalila Children’s Genomics Center, Al Jalila Childrens Speciality Hospital | Feb 11, 2020 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at